S-1 is one of the key drugs widely administrated not only for the adjuvant chemotherapy of gastric cancer but also for the chemotherapy of various cancers such as unresectable advanced gastric cancer, pancreatic cancer, gallbladder cancer, colorectal cancer, head and neck cancer, and breast cancer in Japan. This evidence concerns the gene PSMD1 and breast cancer.